The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2
Transcriber’s notes :
In this transcription a black dotted underline indicates a hyperlink to a page, illustration or footnote; hyperlinks are also marked by aqua highlighting when the mouse pointer hovers over them. A red dashed underline indicates the presence of a hidden comment that can be revealed by hovering the mouse pointer over the underlined text. Page numbers are shown in the right margin.
The text contains some uncommon characters that will not necessarily display correctly with all viewing devices. If some of the characters look abnormal, first ensure that the device’s character encoding is set to Unicode (UTF-8). The default font might also need to be changed to a Unicode font such as Arial Unicode MS, DejaVu, Segoe UI Symbol or FreeSerif. Symbols representing male and female have been replaced by M and F in the handheld version. Subscripted and superscripted characters do not always display correctly on handheld devices.
Several large tables have been compressed in size to enable viewing on small screens and when necessary a key has been added to identify the column headings.
VOLUME 2
Part I
Reports of the Council
Part II
Contributions from the Laboratory
Part III
Journal Contributions: Proprietary Products
Part IV
Council on Pharmacy and Chemistry
---
PREFACE TO VOLUME 2
PREFACE TO VOLUME 1: NINTH EDITION
RESOLUTION ENDORSING THE WORK OF THE COUNCIL ON PHARMACY AND CHEMISTRY
Presented at the San Francisco Session and Signed by All the Members of the House of Delegates in Attendance
TABLE OF CONTENTS
FOREWORD
THE COUNCIL ON PHARMACY AND CHEMISTRY
OFFICIAL RULES OF THE COUNCIL ON PHARMACY AND CHEMISTRY
“ACCEPTED BY THE COUNCIL ON PHARMACY AND CHEMISTRY”
HELPING THE COUNCIL
DELAYS IN PASSING ON PRODUCTS
COOPERATION OF THE PHARMACEUTICAL HOUSES
RHEUMALGINE
GRAY’S GLYCERINE TONIC
TONGALINE AND PONCA COMPOUND
ALFATONE
ARTICLES REFUSED RECOGNITION
FORMAMINT
HYDRAGOGIN
FILUDINE
LACTOPEPTINE AND ELIXIR LACTOPEPTINE
IODUM-MILLER AND IOD-IZD-OIL (MILLER’S)
ELIXIR IODO-BROMIDE OF CALCIUM COMP. “WITHOUT MERCURY” AND “WITH MERCURY”
LECITHIN PREPARATIONS OMITTED FROM N. N. R.
PROPRIETARY NAMES FOR LIQUID PETROLATUM
SENG
FROSST’S BLAUD CAPSULES
TYREE’S ELIXIR OF BUCHU AND HYOSCYAMUS COMPOUND
HYDROLEINE
CURATIVE VACCINE, BRUSCHETTINI
STEARNS’ WINE
PROTONUCLEIN AND PROTONUCLEIN BETA
HYDROPSIN
DIGITALYSATUM
SO-CALLED SECRETIN PREPARATIONS
ARTICLES REFUSED RECOGNITION
THE HYPOPHOSPHITE FALLACY
PULVOIDS CALCYLATES
SULFURYL MONAL
MARK WHITE GOITER SERUM AND MARK WHITE IODINIZED OIL
KORA-KONIA
THE THERAPEUTIC VALUE OF THE GLYCEROPHOSPHATES
HYDRAS
BROMIN-IODIN COMPOUND
AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
ALPHOZONE OMITTED FROM N. N. R.
CALCIUM GLYCEROPHOSPHATE AND SODIUM GLYCEROPHOSPHATE OMITTED FROM N. N. R.
GARDNER’S SYRUP OF AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
GLUTEN PRODUCTS MADE BY THE KELLOGG FOOD COMPANY
IODO-MANGAN OMITTED FROM N. N. R.
LIQUID ALBOLENE
NAPHEY’S MEDICATED UTERINE WAFERS
NUJOL
PULVOIDS NATRIUM COMPOUND
SALOFORM
SECRETOGEN
IRON CITRATE GREEN
ASPIRIN
PIL. CASCARA COMPOUND-ROBINS
CASTA-FLORA
FIRWEIN
FIROLYPTOL PLAIN AND FIROLYPTOL WITH KREOSOTE
BINIODOL
COMPARATIVE SYMPTOMS RESULTING FROM THE USE OF SEVERAL OILY SUSPENSIONS OF RED MERCURIC IODID (MERCURY BINIODID)
WHEELER’S TISSUE PHOSPHATES
WHEELER’S TISSUE PHOSPHATES
THE CLAIMED GALACTAGOGUE EFFECTS OF NUTROLACTIS AND GOAT’S RUE NOT SUBSTANTIATED
THE RUSSELL EMULSION AND THE RUSSELL PREPARED GREEN BONE
BROM-I-PHOS
CREOSOTE-DELSON AND CREOFOS
TRINER’S AMERICAN ELIXIR OF BITTER WINE
TRIMETHOL
FERRIVINE, INTRAMINE AND COLLOSOL IODINE
ESKAY’S NEURO PHOSPHATES
K-Y LUBRICATING JELLY
ZIRATOL
GONOSAN
ALCRESTA IPECAC
IODEOL AND IODAGOL
CAPSULES BISMUTH RESORCINOL COMPOUND NOT ADMITTED TO N. N. R.
DIXON’S TUBERCLE BACILLI EXTRACT AND DIXON’S SUSPENSION OF DEAD TUBERCLE BACILLI
FORMOSOL
IODOLENE, A SOLUTION OF IODIN IN LIQUID PETROLATUM, INADMISSIBLE TO N. N. R.
KALAK WATER
MINSON’S SOLUBLE IODIN “KELPIDINE” NOT ADMITTED TO N. N. R.
NUTONE
TRI-ARSENOLE, L. O. COMPOUND NO. 1 AND L. O. COMPOUND NO. 2
UNCTOL
V-E-M (SCHOONMAKER LABORATORIES, INC.)
HEMO-THERAPIN
VENOSAL
SECRETIN-BEVERIDGE AND THE U. S. PATENT LAW
THE QUESTION OF THE STABILITY OF SECRETIN
NEED FOR PATENT LAW REVISION
SURGODINE
MEDEOL SUPPOSITORIES
GUAIODINE
SEVERAL “MIXED” VACCINES NOT ADMITTED TO N. N. R.
OPHTHALMOL-LINDEMANN
SILVOL INELIGIBLE FOR N. N. R.
KATHARMON
IODINIZED EMULSION (SCOTT) AND CREOSOTONIC (SCOTT)
CAMPETRODIN AND CAMPETRODIN NO. 2
CARMINZYM
PHILLIPS’ PHOSPHO-MURIATE OF QUININE COMP.
B. IODINE AND B. OLEUM IODINE
B. IODINE PRODUCTS
ANTITHYROID PREPARATIONS (ANTITHYROIDIN-MOEBIUS AND THYREOIDECTIN) OMITTED FROM N. N. R.
CEPHAELIN AND SYRUP CEPHAELIN-LILLY OMITTED FROM N. N. R. AND SYRUP EMETIC-LILLY NOT ACCEPTED
COLALIN OMITTED FROM N. N. R.
FORAL
GRANULAR EFFERVESCENT BROMIDE AND ACETANILID COMPOUND-MULFORD
HOLADIN AND BILE SALT MIXTURES
MALTZYME, MALTZYME WITH CASCARA SAGRADA, MALTZYME WITH COD LIVER OIL, MALTZYME FERRATED AND MALTZYME WITH YERBA SANTA OMITTED FROM N. N. R.
METHAFORM OMITTED FROM N. N. R.
PINEAL GLAND, RED BONE-MARROW AND THYMUS GLAND AND THEIR PREPARATIONS OMITTED FROM N. N. R.
PIPERAZINE AND LYCETOL OMITTED FROM N. N. R.
STANOLIND LIQUID PARAFFIN OMITTED FROM N. N. R.
WESTERFIELD’S DIGITALIS TABLETS
XEROFORM-HEYDEN AND BISMUTH TRIBROMPHENATE-MERCK OMITTED FROM N. N. R.
CREAM OF MUSTARD REFUSED RECOGNITION
“PLURIGLANDULAR” MIXTURES
CERELENE NOT ADMITTED TO N. N. R.
COLLOSOL COCAINE NOT ADMITTED TO N. N. R
CUPRASE NOT ADMITTED TO N. N. R.
COLLOSOL PREPARATIONS
PULVOIDS CALCYLATES COMPOUND
PROTEOGENS OF THE WM. S. MERRELL COMPANY
“ARSENOVEN S. S.” AND “ARSENO-METH-HYD”
HORMOTONE AND HORMOTONE WITHOUT POST-PITUITARY
FORMALDEHYDE LOZENGES
LAVORIS
MEDINAL
OMISSION OF COTARNIN SALTS (STYPTICIN AND STYPTOL) FROM N. N. R.
MICAJAH’S WAFERS AND MICAJAH’S SUPPOSITORIES
ALKALITHIA
ARHOVIN OMITTED FROM N. N. R.
CHLORON, CHLORAX AND NUMBER “3”
ELARSON OMITTED FROM N. N. R.
IODIPHOS
MERVENOL AND ARMERVENOL NOT ADMITTED TO N. N. R.
NORMAL PHENOL SERUM (CANO) AND METHYL-PHENOL SERUM (CANO) NOT ACCEPTED FOR N. N. R.
SOAMIN OMITTED FROM N. N. R.
SOME MIXED VACCINES NOT ADMITTED TO N. N. R.
SOMNOFORM
TABLETS FORMOTHALATES
TRIPLE ARSENATES WITH NUCLEIN
“ANTI-PNEUMOCOCCIC OIL” AND THE USE OF CAMPHOR IN PNEUMONIA
DIAL “CIBA”
APOTHESINE
EUMICTINE
PLATT’S CHLORIDES
ANTI-TUBERCULOUS LYMPH COMPOUND (SWEENY) AND ANTI-SYPHILITIC COMPOUND (SWEENY)
SYRUP LEPTINOL (FORMERLY SYRUP BALSAMEA)
FORMITOL TABLETS, II
SUKRO-SERUM AND APHLEGMATOL
SUPSALVS NOT ADMITTED TO N. N. R.
HYPODERMIC SOLUTION NO. 13, IRON, ARSENIC AND PHOSPHORUS COMPOUND NOT ACCEPTED FOR N. N. R.
PARATHESIN NOT ADMITTED TO N. N. R.
CHLORLYPTUS
I. DETAILED REPORTS
B. THE PERSISTENCE OF THE ACID
C. TOXICITY EXPERIMENTS
D. REPORT OF DR. D. RIVAS
AQUAZONE (OXYGEN WATER)
COAGULEN-CIBA OMITTED FROM N. N. R.
FERRIC CACODYLATE OMITTED FROM NEW AND NONOFFICIAL REMEDIES
LIBRADOL
HELMITOL OMITTED FROM N. N. R.
SPIROCIDE NOT ADMITTED TO N. N. R.
DIGIFOLIN-CIBA NOT ADMITTED TO N. N. R.
SOME OF LOESER’S INTRAVENOUS SOLUTIONS
“NATIONAL IODINE SOLUTION” NOT ADMITTED TO N. N. R.
MON-ARSONE NOT ADMITTED TO N. N. R.
OXYL-IODIDE NOT ADMITTED TO N. N. R.
QUASSIA COMPOUND TABLETS
TOXICIDE
PIL. MIXED TREATMENT (CHICHESTER)
ATOPHAN OMITTED FROM N. N. R.
UROTROPIN OMITTED FROM N. N. R.
STYPTYSATE NOT ADMITTED TO N. N. R.
LIPOIDAL SUBSTANCES (HOROVITZ) NOT ADMITTED TO N. N. R.
YEAST PREPARATIONS AND VITAMIN B CONCENTRATES
FOREWORD
THE CHEMICAL LABORATORY OF THE AMERICAN MEDICAL ASSOCIATION
LEAD IN “AKOZ”
SODIUM ACETATE IN WARMING BOTTLES
ANTI-SYPHILITIC COMPOUND (SWEENY)
THE STABILITY OF IODINE OINTMENTS
IODOLENE AND THE SOLUBILITY OF IODIN IN LIQUID PETROLATUM
AMERICAN-MADE SYNTHETIC DRUGS—I
THE STANDARDIZATION OF COMMERCIAL BISMUTH TRIBROMPHENATE
THE STANDARDIZATION OF PROCAIN AND EXAMINATION OF THE MARKET SUPPLY
DETERIORATION OF SODIUM HYPOCHLORITE SOLUTIONS (“Chlorinated Soda” Solutions)
SYPHILODOL
CERELENE
DR. DE SANCTIS’ RHEUMATIC AND GOUT PILLS
IODEX AND LIQUID IODEX
I. G. O.
IODIN IN LIQUID PETROLATUM
AMERICAN-MADE SYNTHETIC DRUGS—II
NOSTRUMS IN RETROSPECT
[Article I]
[Article II]
[Article III]
[Article IV]
[Article V]
[Article VI]
[Article VII]
[Article VIII]
[Article IX]
ANTIMERISTEM-SCHMIDT
ANTIPHLOGISTINE
“AUTO-HEMIC SERUM”
“AUTOLYSIN” ADVERTISING
“BASIC CANCER RESEARCH” AND “COSMOPOLITAN CANCER RESEARCH SOCIETY”
CAMPHO-PHENIQUE
“CINCHOPHEN”: FORMERLY “ATOPHAN”
“COLLOSOLS”: AN UNCRITICAL ENGLISH ENDORSEMENT
COTTON PROCESS ETHER
DIONOL
THE ELI PRODUCTS OF ELI H. DUNN
GLOVER’S CANCER SERUM
GLYCO-THYMOLINE AND POLIOMYELITIS
GRAY’S GLYCERINE TONIC: “WHOSE BREAD I EAT HIS SONG I SING”
HAGEE’S CORDIAL OF COD LIVER OIL
HYPNO-BROMIC COMPOUND
INTRAVENOUS COMPOUND (LOFFLER)
INTRAVENOUS SPECIALTIES
IODEX
THE WILLIAM F. KOCH CANCER REMEDY
THE LUCAS LABORATORIES’ PRODUCTS
PINEOLEUM ADVERTISING METHODS
“PROTEAL THERAPY” AND HENRY SMITH WILLIAMS
PROTEOGENS
PULVANE
SAL HEPATICA
SALICON
SO-CALLED SECRETIN PREPARATIONS
SUCCUS CINERARIA MARITIMA
TEKARKIN
TYREE’S ANTISEPTIC POWDER AGAIN
WHEELER’S TISSUE PHOSPHATES
BRIEFER PARAGRAPHS
ALBERT ABRAMS, A.M., M.D., LL.D., F.R.M.S.
ACETYLSALICYLIC ACID, NOT ASPIRIN
THE ALLIED MEDICAL ASSOCIATIONS OF AMERICA
“ARSENICALS”
BEER AND CANCER CURES
BIOLOGIC THERAPEUTICS AND ITS COMMERCIAL DOMINATION
CAPELL’S UROLUETIC TEST
THE DIRECT SALES COMPANY
DISCOVERIES AND DISCOVERERS
“DRUG REFORM”
DRUG THERAPY: THE FALLIBILITY OF TEXTBOOKS
THOMAS WEBSTER EDGAR
GLYCEROPHOSPHATES
INFLUENZA VACCINES
INTRAVENOUS THERAPY
IODIN FUMES
ITALIAN PHYSICO-CHEMICAL COMPANY
WHAT IS LIQUID PETROLATUM?
THE LOWENTHAL POSTGRADUATE COURSE
MEDICAL SOCIETY OF THE UNITED STATES
THE NATIONAL FORMULARY—A REVIEW OF THE FOURTH EDITION
NONSPECIFIC PROTEIN THERAPY
WILLARD EALON OGDEN
“PATENTS”
PHARMACEUTICAL BARNUMS
THE PHARMACOPEIA
PHYSICIAN’S STOCK IN PRESCRIPTION PRODUCTS
PITUITARY GLAND PREPARATIONS
PROPRIETORSHIP IN MEDICINE
PHILIP RAHTJEN AND HIS DISCOVERIES
SODIUM CACODYLATE IN SYPHILIS
TABLETS: DEPENDABILITY OF DOSAGE
“VACCINES IN TOXIC CONDITIONS”
VITAMINS: THEIR DISTRIBUTION
THE WILLIAM A. WEBSTER CO. AND THE DIRECT PHARMACEUTICAL CO.
YEAST
BRIEFER PARAGRAPHS
INDEX AND BIBLIOGRAPHY
FOOTNOTES:
